1. Home
  2. RCAT vs PVLA Comparison

RCAT vs PVLA Comparison

Compare RCAT & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$10.46

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$146.76

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCAT
PVLA
Founded
2002
2015
Country
United States
United States
Employees
N/A
29
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
RCAT
PVLA
Price
$10.46
$146.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
15
Target Price
$20.00
$171.87
AVG Volume (30 Days)
12.3M
322.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,836,382.00
N/A
Revenue This Year
$271.60
N/A
Revenue Next Year
$41.21
$104,350.18
P/E Ratio
N/A
N/A
Revenue Growth
79.95
N/A
52 Week Low
$5.77
$23.86
52 Week High
$18.78
$161.38

Technical Indicators

Market Signals
Indicator
RCAT
PVLA
Relative Strength Index (RSI) 46.61 63.82
Support Level $9.08 $106.07
Resistance Level $13.69 $151.18
Average True Range (ATR) 0.94 9.05
MACD -0.06 3.70
Stochastic Oscillator 46.88 74.17

Price Performance

Historical Comparison
RCAT
PVLA

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: